SomnoMed Ltd

SOM

Company Profile

  • Business description

    SomnoMed Ltd provides treatment solutions for sleep-related breathing disorders, including obstructive sleep apnea, snoring, and bruxism. It is engaged in commercializing SomnoDent Mandibular Advancement Splint (MAS) and other oral devices for sleep-related disorders in Australia and overseas. The other products in the company's portfolio include SomMorning Repositioner; SomnoBrux splint, a custom-fit, acrylic splint (dental guard) for upper teeth designed to protect teeth from grinding and scraping during Bruxism; and SomTabs cleaning tablets that have been developed to clean oral appliances. Geographically, the company generates maximum revenue from Europe, followed by North America and the Asia Pacific region.

  • Contact

    20 Clarke Street
    Level 3
    Crows Nest
    SydneyNSW2065
    AUS

    T: +61 294670400

    https://www.somnomed.com.au

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    30 June 2027

    Employees

    22

Stocks News & Analysis

stocks

ASX energy share undervalued ahead of earnings

Pricing strength outweighs temporary production headwinds.
stocks

Tesla: Reported China divestiture plan could clear path for SpaceX merger

Media report says Tesla is exploring divestiture plans to ease regulatory approval of a Tesla-SpaceX merger.
stocks

This onetime AI market darling is now surprisingly undervalued

This AI leader qualifies as a GARP stock today.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,178.4069.700.77%
CAC 408,613.82104.181.22%
DAX 4026,001.31372.071.45%
Dow JONES (US)52,988.47503.440.96%
FTSE 10010,857.7010.35-0.10%
HKSE26,009.40124.970.48%
NASDAQ25,893.77519.912.05%
Nikkei 22563,754.90607.12-0.94%
NZX 50 Index13,774.9375.650.55%
S&P 5007,588.9599.231.32%
S&P/ASX 2009,019.3070.300.79%
SSE Composite Index3,809.6622.60-0.59%

Market Movers